Page last updated: 2024-09-04

moxifloxacin and evacetrapib

moxifloxacin has been researched along with evacetrapib in 1 studies

Compound Research Comparison

Studies (moxifloxacin)	Trials (moxifloxacin)	Recent Studies (post-2010) (moxifloxacin)	Studies (evacetrapib)	Trials (evacetrapib)	Recent Studies (post-2010) (evacetrapib)
3,157	552	1,690	75	20	72

Protein Interaction Comparison

Protein	Taxonomy	moxifloxacin (IC50)	evacetrapib (IC50)
Cholesteryl ester transfer protein	Homo sapiens (human)		0.11

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Friedrich, S; Krueger, KA; Suico, JG; Zhang, W	1

Trials

1 trial(s) available for moxifloxacin and evacetrapib

Article	Year
Evacetrapib at a supratherapeutic steady state concentration does not prolong QT in a thorough QT/QTc study in healthy participants. Journal of cardiovascular pharmacology and therapeutics, 2014, Volume: 19, Issue:3 Topics: Adult; Aged; Anti-Bacterial Agents; Area Under Curve; Benzodiazepines; Body Mass Index; Cholesterol Ester Transfer Proteins; Cross-Over Studies; Dose-Response Relationship, Drug; Electrocardiography; Female; Fluoroquinolones; Half-Life; Humans; Male; Moxifloxacin; Tachycardia, Ventricular	2014

Article

Year

Evacetrapib at a supratherapeutic steady state concentration does not prolong QT in a thorough QT/QTc study in healthy participants.

Journal of cardiovascular pharmacology and therapeutics, 2014, Volume: 19, Issue:3

Topics: Adult; Aged; Anti-Bacterial Agents; Area Under Curve; Benzodiazepines; Body Mass Index; Cholesterol Ester Transfer Proteins; Cross-Over Studies; Dose-Response Relationship, Drug; Electrocardiography; Female; Fluoroquinolones; Half-Life; Humans; Male; Moxifloxacin; Tachycardia, Ventricular

2014